Insulin-like growth factor-related signaling and cancer development.
In this review, selected examples of recent research developments concerning insulin-like growth factors (IGFs) and insulin in the context of cancer risk assessment and prevention will be discussed. We reviewed background information related to IGF physiology at the cellular and whole-organism levels, together with prior work concerning IGF-I levels and risk of a variety of cancers, including breast, prostate, colon, and lung in 2004 (Pollak et al. 2004). A comprehensive update to that general review (Pollak et al. 2004) is scheduled for Nature Reviews Cancer in early 2007.
Pollak
Michael
M
General Jewish Hospital, Medicine and Oncology, Montreal, Quebec, Canada.
D000818:Animals; D002471:Cell Transformation, Neoplastic; D006801:Humans; D007328:Insulin / Q000378:metabolism; D009369:Neoplasms; D012307:Risk Factors; D015398:Signal Transduction / Q000502:physiology*; D013002:Somatomedins / Q000378:metabolism*
D007328:Insulin; D013002:Somatomedins